Announce Date | 08/07/2025 |
EPS Normalized Actual | $-0.75216 (Miss by $-0.87216) |
EPS GAAP Actual | $-0.75216 (Miss by $-0.87216) |
Revenue Actual | $17.857B |
Revenue Surprise | Beat by $17857M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $1.66167 |
EPS GAAP Estimate | $1.66167 |
Revenue Estimate | $21.057594651B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 5.19212 | 0.67 | 4.6416 | 5.82083 | 1 |
Dec 2028 | 0 | INF | 0 | 0 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.66 | -2.14977 | 17.857B | -6.82% | -2513.03M |
FQ1 2025 (Mar 2025) | 1.76 | 1.41941 | 19.46B | 7.91% | -1612.48M |
FQ4 2024 (Dec 2024) | -7.09 | -5.38295 | 19.152B | 12.85% | 15699.82M |
FQ3 2024 (Sep 2024) | -0.74 | -0.87895 | 21.265B | 21.58% | 17899.32M |
FQ2 2024 (Jun 2024) | -4.69 | -2.65777 | 19.075B | 6.91% | 15638.97M |
FQ1 2024 (Mar 2024) | -1.69 | -2.23 | 17.92B | -8.52% | 13993.79M |
FQ4 2023 (Dec 2023) | -1.98 | -1.55 | 16.6913B | -13.77% | 13051.3M |
FQ3 2023 (Sep 2023) | -6.07 | -6.07 | 16.676B | -52.24% | 16676M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
1.66167
Consensus Revenue Estimates
21.057594651B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 4.4945 | -- | 4.46521 | 4.52379 | 1 |
FQ3 2026 (Sep 2026) | 0.13101 | -- | 0.13101 | 0.13101 | 1 |
FQ2 2026 (Jun 2026) | 0.87344 | 175.56 | 0.87344 | 0.87344 | 1 |
FQ1 2026 (Mar 2026) | 1.32842 | -32.49 | 1.31976 | 1.33708 | 1 |
FQ4 2025 (Dec 2025) | 0.71703 | 1088.8 | 0.70489 | 0.72917 | 1 |
FQ3 2025 (Sep 2025) | 1.66167 | 144.53 | 1.66167 | 1.66167 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 21.64B | -- | 21.53B | 21.74B | 1 |
FQ3 2026 (Sep 2026) | 23.96B | -- | 23.96B | 23.96B | 4 |
FQ2 2026 (Jun 2026) | 23.21B | 23.05 | 23.21B | 23.21B | 4 |
FQ1 2026 (Mar 2026) | 19.66B | 1 | 19.56B | 19.75B | 1 |
FQ4 2025 (Dec 2025) | 23.28B | 17.73 | 22.98B | 23.58B | 0 |
FQ3 2025 (Sep 2025) | 21.06B | -0.98 | 21.06B | 21.06B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 1.48977 | -0.66 | -2.14977 | 325.72% |
FQ1 2025 (Mar 2025) | 0.34059 | 1.76 | 1.41941 | 80.65% |
FQ4 2024 (Dec 2024) | -1.70705 | -7.09 | -5.38295 | 75.92% |
FQ3 2024 (Sep 2024) | 0.13895 | -0.74 | -0.87895 | 118.78% |
FQ2 2024 (Jun 2024) | -2.03223 | -4.69 | -2.65777 | 56.67% |
FQ1 2024 (Mar 2024) | 0.54 | -1.69 | -2.23 | 131.95% |
FQ4 2023 (Dec 2023) | -0.43 | -1.98 | -1.55 | 78.28% |
FQ3 2023 (Sep 2023) | -6.07 | -6.07 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $20.37B | $17.86B | $-2513.03M | -14.07% |
FQ1 2025 (Mar 2025) | $21.07B | $19.46B | $-1612.48M | -8.29% |
FQ4 2024 (Dec 2024) | $3.45B | $19.15B | $15699.82M | 81.97% |
FQ3 2024 (Sep 2024) | $3.37B | $21.27B | $17899.32M | 84.17% |
FQ2 2024 (Jun 2024) | $3.44B | $19.08B | $15638.97M | 81.99% |
FQ1 2024 (Mar 2024) | $3.93B | $17.92B | $13993.79M | 78.09% |
FQ4 2023 (Dec 2023) | $3.64B | $16.69B | $13051.3M | 78.19% |
FQ3 2023 (Sep 2023) | $0B | $16.68B | $16676M | 100% |